PETER J. HOWANITZ MD

Preview:

DESCRIPTION

PETER J. HOWANITZ MD. PROFESSOR, VICE CHAIRMAN & CLINICAL LABORATORY DIRECTOR DEPARTMENT OF PATHOLOGY STATE UNIVERSITY OF NEW YORK Downstate Medical Center Brooklyn , NY, USA Peter.Howanitz@downstate.edu. INTRODUCTION. Definition & Significance Of Hemolysis Discuss Practice Patterns - PowerPoint PPT Presentation

Citation preview

1

PETER J. HOWANITZ MD

PROFESSOR, VICE CHAIRMAN & CLINICAL LABORATORY DIRECTOR

DEPARTMENT OF PATHOLOGYSTATE UNIVERSITY OF NEW YORK

Downstate Medical Center Brooklyn , NY, USA

Peter.Howanitz@downstate.edu

2

INTRODUCTION• Definition & Significance Of Hemolysis• Discuss Practice Patterns• Determine Causes• Propose Improvements• Conclusions

3

Hemolysis is the disruption of the blood cell membrane with the release of the blood cell

contents into the surrounding fluid.

4

SOME IN VIVO HEMOLYSIS CAUSES

• Hemolytic Transfusion Rx, Autoimmune Warm Ab• Hereditary Spherocytosis, G6PD Def, Sickle Cell• Hemolytic Transfusion Rx, Autoimmune Warm Ab• Anti-malarials, Aspirin, Chloramphenicol• Malaria, Clostridia, DIC• Burns, Liver & Renal Disease, PNH• March Hemoglobinuria, Prosthetic Heart Valves

5

PHLEBOTOMY RELATED CAUSES

Catheter IV CollectionDrawn From Hematoma

Capillary CollectionPhlebotomy EquipmentPhlebotomy Antiseptic

Tourniquet Time

Lippi….Green et al. Clin Chem Lab Med 2009;47:143

Location of StickNo Mixing In Tube

Vigorous Mixing In TubeTraumatic Draw

Tube Under FillingSyringe Transfer

6

PRACTICE PATTERNS OF HEMOLYSIS

7

CAP QUALITY PRACTICES COMMITTEE STUDY

Q-Probes FormatCAP Chemistry Resource Committee Assistance

7 CAP Chemistry Survey Participants On-Line Questionnaire

28 Multiple Choice Questions7 “Other, Please List” Questions

846 Participants

8

0%

5%

10%

15%

20%

25%

30%

35%

40%36% 35%

15%

4%1%

9%

LABORATORY OVERALL HEMOLYSIS RATE (%)

LABORATORY CATEGORY BASED ON HEMOLYSIS RATE

9

PROCEDURES USED FOR HEMOLYSIS ID

Parameter % Yes % No % Unsure

Hemolysis visually graded compared to a picture 40 57 3

Visual grading evaluated by competency assessment 18 73 9

Manual procedures identify hemolysis in difficult cases 8 88 4

Able to send automated hemolysis flags to med record 36 50 14

Used automated result verification primary chem analyzer 32 66 2

Same hemolysis scale all analytes primary chem analyzer 81 14 5

Same hemolysis scale primary chem & IA analyzer 70 23 8

Same hemolysis scale primary & backup chem analyzer 74 19 7

Systematically/regularly monitors hemolyzed specimens 47 46 7

10

HEMOLYSIS SCALES USED 710 LABS

11

HEMOLYSIS REJECTION PRACTICES

12

21/69 MOST COMMONLY USED HEMOLYSIS DESCRIPTIVE TERMS

13

USE OF 20 CUTOFF HEMOLYSIS TERMS

14

ANALYTE SPECIFIC HEMOLYSIS POLICIES

15

ATTEMPTED TO VALIDATE HEMOLYSIS FOR ANALYTES

Any

Potassium

Glucose

LD

0% 5% 10% 15% 20% 25% 30% 35%

30%

29%

24%

23%

16

CORRECTIVE ACTION DURING PAST YEAR

17

LACK OF SUCCESS IN HEMOLYSIS REDUCTION (N=567)

18

PHLEBOTOMY RELATED CAUSES

Catheter IV CollectionDrawn From Hematoma

Capillary CollectionPhlebotomy EquipmentPhlebotomy Antiseptic

Tourniquet Time

Lippi et al. Clin Chem Lab Med 2009;47:143

Location of StickNo Mixing In Tube

Vigorous Mixing In TubeTraumatic Draw

Tube Under FillingSyringe Transfer

19

WHOLE BLOOD HEMOLYSIS DETECTION

Not Determined

After analyses stored, visually inspected

After analyses centrifuged, visually inspected

K+ elevated,other tubes evaluated

K+ elevated, centrifuged, visually inspected

0% 10% 20% 30% 40% 50% 60%

56%

10%

21%

3%

3%

20

CASE REPORTIsmail et al BMJ 330:949,2005

40 Year Old Woman Admitted –Dx SLE5 Days Vomiting, Diarrhea, Weakness

Hb 8.9 g/dl, WBC 6.1 X109 BUN 87 mg/dl Creatinine 4.8 mg/dl

Blood Smear –Diffuse Fragmented Cells Consistent With Microhemangiopathic Hemolytic Anemia

Potassium Cancelled-Hemolyzed

Peter Howanitz

21

CASE REPORT CONTINUEDDx-Hemolytic Uremic Syndrome &

Acute Renal Failure Treated Aggressively, & Planned To

Transfer To Dialysis Next DayCardiac Arrest & Died

POST MORTEM ? KIf Known, Immediate Dialysis?

22

RECENT INSTRUMENTATION ADVANCES

• Measure Hemolysis• Download Hemolysis To LIS• Provide Extensive Hemolysis Evaluations• Allow Unique Hemolysis Flag By Analyte• Hemolysis Measurements FDA Approved

23

COST OF HEMOLYSIS• $203,037 /Yr• Reduced Hemolysis 19.8% To 4.9%• Singapore General Hospital ED• 200 ‘Lyes & Bun/Day• $18.67/Test

Ong et al Am J Med 2009: 122:1054

24

COST OF HEMOLYSIS• ICU/DAY•Hospital Charge/Day

25

SAME HEMOLYSIS FLAGS AS LIPEMIA OR ICTERUS

LD Glucose Potassium Other0%

10%

20%

30%

40%

50%

60%

70%

53%58%

61%

37%

54% 55%

64%

36%

Lipemia Icterus

26

AIDS FOR IMPROVEMENT

27

VALIDITY OF DATA ON CAUSES

• Many Studies By Nursing Personnel• Difficulty In Controlling Variables• Unaware Lab vs Nursing Phlebotomists• Some Data Conflicting• Need For Published Studies

28

VENIPUNCTURE VERSUS IV CATHETER

Lowe et al. J Emerg Nurs 2008, 34: 26-32

29

FIVE IMPROVEMENT SUGGESTIONS

Do Not Reject Hemolyzed SpecimensDevelop Interdepartmental Team(s)

Choose Instruments That Quantitate HemolysisMonitor & Share Successes With Administration

Select Aids For Improvement

30

CONCLUSIONS

• Definition & Significance Of Hemolysis• Discussed Clinical Laboratory Practice

Patterns• Established Causes• Provided Suggestions For Improvements

Recommended